Overview
- First-half fiscal 2026 organic sales fell 2.8% after the company had previously expected roughly flat performance for the year.
- Management reduced full-year guidance and declared an interim dividend of $0.20 per share, down from $0.405 a year earlier.
- Shares dropped 10.8% for the week, according to S&P Global Market Intelligence, reversing much of the stock’s recent recovery.
- Reporting cited U.S. market softness as a key pressure point that contributed to the sell-off.
- Commentator Jim Cramer criticized management’s stance and pointed to factors he says are weighing on demand, including tighter consumer budgets, lower alcohol use among younger buyers, GLP-1 drug effects, and legal cannabis competition.